ChemicalBook > Product Catalog >Biochemical Engineering >Biochemical Reagents >Agonist Inhibitors >KRP-203

KRP-203

KRP-203 Suppliers list
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532 18210857532
Email: jkinfo@jkchemical.com
Company Name: Nanjing Chemlin Chemical Co., Ltd  
Tel: 025-83697070 13770331960
Email: info@chemlin.com.cn
Company Name: Chemsky(shanghai)International Co.,Ltd.  
Tel: 021-50135380
Email: shchemsky@sina.com
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: Hubei XinyuanShun Chemical Co., Ltd.  
Tel: 13971561712, 13995564702, 027-50664929
Email: hbeixys2001@163.com
KRP-203 Basic information
Product Name:KRP-203
Synonyms:2-Amino-2-[2-[2-chloro-4-[[3-(phenylmethoxy)phenyl]thio]phenyl]ethyl]-1,3-propanediol Hydrochloride;KRP-203;2-Amino-2-(2-(4-(3-benzyloxyphenylthio)-2-chlorophenyl)ethyl)-1,3-propanediol hydrochloride;KRP-203 (hydrochloride);2-Amino-2-(4-((3-(benzyloxy)phenyl)thio)-2-chloro-phenethyl)propane-1,3-diol hydrochloride;KRP203/2-AMino-2-(2-(4-(3-benzyloxyphenylthio)-2-chlorophenyl)ethyl)-1,3-propanediol hydrochloride;2-Amino-2-[2-[2-chloro-4-[[3-(phenylmethoxy)phenyl]thio]phenyl]ethyl]-1,3-propanediol;2-AMINO-2-[2-[2-CHLORO-4-[[3-(PHENYLMETHOXY)PHENYL]THIO]PHENYL]ETHYL]-1,3-PROPANEDIOL HCL
CAS:509088-69-1
MF:C24H27Cl2NO3S
MW:480.45
EINECS:1312995-182-4
Product Categories:Intermediates & Fine Chemicals;Pharmaceuticals;Amines;Aromatics;Sulfur & Selenium Compounds
Mol File:509088-69-1.mol
KRP-203 Structure
KRP-203 Chemical Properties
Melting point 199-200 ºC (DEC.)
storage temp. Refrigerator
solubility DMSO, Methanol
form Solid
color White to Off-White
Safety Information
MSDS Information
KRP-203 Usage And Synthesis
UsesA novel immunomodulator
UsesA novel sphingosine-1-phosphate receptor agonists in the treatment of autoimmune diseases. Immunosuppressant.
in vivo

Mocravimod hydrochloride (KRP-203) ameliorates atherosclerosis in LDL-R / Mice[1].
Mocravimod hydrochloride (KRP-203) (orally; 0.1 and 1 mg/kg/day; for 100 days) prolongs graft survival and attenuates chronic rejection in mHC-disparate rat heart allografts[2].

Animal Model:Inbred male DA (MHC haplotype: RT1a) rats[2]
Dosage:0.1 and 1 mg/kg
Administration:Orally; daily; for 100 days
Result:Prolonged graft survival and attenuated chronic rejection in mHC-disparate rat heart allografts.
KRP-203 Preparation Products And Raw materials
Tag:KRP-203(509088-69-1) Related Product Information
KRP-203 Mocravimod Amiselimod(MT-1303) hydrochloride 5-[(2,4-Dioxo-1,3-thiazolidin-5-yl)methyl]-2-methoxy-N-[4-(trifluoromethyl)benzyl]benzamide Ozanimod Merck SIP Agonist